Journey Medical (DERM) Gross Profit (2020 - 2025)
Historic Gross Profit for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $11.9 million.
- Journey Medical's Gross Profit rose 1691.28% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year decrease of 22.38%. This contributed to the annual value of $35.3 million for FY2024, which is 3736.68% down from last year.
- Journey Medical's Gross Profit amounted to $11.9 million in Q3 2025, which was up 1691.28% from $10.1 million recorded in Q2 2025.
- Journey Medical's Gross Profit's 5-year high stood at $28.1 million during Q3 2023, with a 5-year trough of $5.8 million in Q1 2023.
- In the last 5 years, Journey Medical's Gross Profit had a median value of $8.9 million in 2024 and averaged $10.3 million.
- Per our database at Business Quant, Journey Medical's Gross Profit soared by 21602.02% in 2023 and then crashed by 6386.34% in 2024.
- Journey Medical's Gross Profit (Quarter) stood at $8.0 million in 2021, then increased by 3.2% to $8.2 million in 2022, then skyrocketed by 57.72% to $13.0 million in 2023, then plummeted by 31.28% to $8.9 million in 2024, then surged by 32.84% to $11.9 million in 2025.
- Its Gross Profit was $11.9 million in Q3 2025, compared to $10.1 million in Q2 2025 and $8.3 million in Q1 2025.